Physician profile
Craig Eldridge
NPI 1366833840
$1,100.69
in general payments reported to CMS, 2019-2025
12 companies · $339 in 2025
The $339 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $169 · 2022: $221 · 2023: $238 · 2024: $135 · 2025: $339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $711.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $711.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $414.66 | 2021-2025 | Dupixent, Libtayo |
| Genzyme Corporation | $159.14 | 2021-2024 | |
| Viiv Healthcare Company | $122.39 | 2025 | Apretude |
| Axogen | $102.66 | 2025 | |
| Glaxosmithkline, LLC. | $47.64 | 2021-2022 | |
| Depuy Synthes Sales INC. | $45.90 | 2025 | Trumatch |
| Alk-Abello, INC | $45.43 | 2021-2022 | |
| Optinose US, INC. | $44.32 | 2023 | |
| Inspire Medical Systems, INC. | $40.60 | 2023-2024 | Inspire |
| Acera Surgical, INC. | $28.50 | 2025 | Restrata Wound Matrix |
| Myriad Genetic Laboratories, INC. | $27.81 | 2022 | |
| Davol INC. | $21.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Eldridge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.